172 related articles for article (PubMed ID: 10693150)
1. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
[TBL] [Abstract][Full Text] [Related]
3. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
Martínez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
5. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
Stenzel-Poore MP; Heinrichs SC; Rivest S; Koob GF; Vale WW
J Neurosci; 1994 May; 14(5 Pt 1):2579-84. PubMed ID: 8182429
[TBL] [Abstract][Full Text] [Related]
6. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
[TBL] [Abstract][Full Text] [Related]
8. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Kask A; Rägo L; Harro J
Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
[TBL] [Abstract][Full Text] [Related]
9. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
Martínez V; Rivier J; Taché Y
J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
[TBL] [Abstract][Full Text] [Related]
10. Stimulant and anxiogenic effects of corticotropin releasing factor.
Koob GF; Thatcher-Britton K
Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
[TBL] [Abstract][Full Text] [Related]
11. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.
Rivier J; Gulyas J; Corrigan A; Martinez V; Craig AG; Taché Y; Vale W; Rivier C
J Med Chem; 1998 Dec; 41(25):5012-9. PubMed ID: 9836619
[TBL] [Abstract][Full Text] [Related]
12. Central activation of thermogenesis by prostaglandins: dependence on CRF.
Rothwell NJ
Horm Metab Res; 1990 Dec; 22(12):616-8. PubMed ID: 2076859
[TBL] [Abstract][Full Text] [Related]
13. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
Diamant M; de Wied D
Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF.
Million M; Taché Y; Anton P
Am J Physiol; 1999 Apr; 276(4):G1027-36. PubMed ID: 10198347
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
Britton KT; Akwa Y; Spina MG; Koob GF
Peptides; 2000 Jan; 21(1):37-44. PubMed ID: 10704717
[TBL] [Abstract][Full Text] [Related]
16. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF.
Jones DN; Kortekaas R; Hatcher PD; Middlemiss DN; White A; Hagan JJ
Eur J Pharmacol; 1999 Jun; 373(2-3):141-5. PubMed ID: 10414432
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
18. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat.
Klausner AP; Streng T; Na YG; Raju J; Batts TW; Tuttle JB; Andersson KE; Steers WD
Auton Neurosci; 2005 Dec; 123(1-2):26-35. PubMed ID: 16256445
[TBL] [Abstract][Full Text] [Related]
19. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats.
Eutamene H; Theodorou V; Fioramonti J; Bueno L
J Physiol; 2003 Dec; 553(Pt 3):959-66. PubMed ID: 14555722
[TBL] [Abstract][Full Text] [Related]
20. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.
Heinrichs SC; Menzaghi F; Pich EM; Baldwin HA; Rassnick S; Britton KT; Koob GF
Neuropsychopharmacology; 1994 Nov; 11(3):179-86. PubMed ID: 7865099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
